San Francisco Sentry Investment Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$506K Buy
6,065
+370
+6% +$30.3K 0.26% 106
2021
Q1
$428K Buy
5,695
+135
+2% +$9.83K 0.18% 144
2020
Q4
$379K Buy
5,560
+300
+6% +$19.5K 0.18% 138
2020
Q3
$307K Buy
5,260
+25
+0.5% +$1.56K 0.16% 148
2020
Q2
$340K Buy
5,235
+2,267
+76% +$143K 0.18% 129
2020
Q1
$176K Sell
2,968
-1,394
-32% -$93.1K 0.11% 161
2019
Q4
$324K Sell
4,362
-356
-8% -$25K 0.15% 157
2019
Q3
$298K Sell
4,718
-215
-4% -$12.7K 0.14% 158
2019
Q2
$269K Sell
4,933
-777
-14% -$41.8K 0.12% 166
2019
Q1
$308K Buy
5,710
+66
+1% +$4.07K 0.13% 159
2018
Q4
$370K Buy
5,644
+4,279
+313% +$319K 0.17% 119
2018
Q3
$107K Buy
1,365
+175
+15% +$12.5K 0.04% 306
2018
Q2
$77K Sell
1,190
-9,530
-89% -$628K 0.03% 341
2018
Q1
$667K Sell
10,720
-85
-0.8% -$6.1K 0.19% 105
2017
Q4
$783K Sell
10,805
-3,295
-23% -$240K 0.23% 93
2017
Q3
$1.15M Sell
14,100
-84
-0.6% -$6.64K 0.39% 63
2017
Q2
$1.14M Sell
14,184
-1,680
-11% -$133K 0.41% 56
2017
Q1
$1.25M Sell
15,864
-963
-6% -$76.9K 0.68% 43
2016
Q4
$1.33M Sell
16,827
-1,285
-7% -$104K 0.77% 38
2016
Q3
$1.61M Sell
18,112
-90
-0.5% -$8.49K 0.95% 28
2016
Q2
$1.74M Buy
18,202
+550
+3% +$54.8K 1.07% 26
2016
Q1
$1.83M Buy
17,652
+1,050
+6% +$102K 1.1% 24
2015
Q4
$1.62M Buy
16,602
+1,045
+7% +$102K 1.02% 27
2015
Q3
$1.5M Buy
15,557
+135
+0.9% +$14.2K 1.06% 23
2015
Q2
$1.62M Buy
15,422
+739
+5% +$75.5K 0.97% 24
2015
Q1
$1.51M Buy
14,683
+3,245
+28% +$328K 0.9% 27
2014
Q4
$1.1M Buy
11,438
+47
+0.4% +$4.14K 0.64% 40
2014
Q3
$907K Buy
11,391
+421
+4% +$33.2K 0.45% 52
2014
Q2
$827K Sell
10,970
-15
-0.1% -$1.13K 0.4% 58
2014
Q1
$822K Buy
10,985
+350
+3% +$24.7K 0.26% 87
2013
Q4
$761K Buy
10,635
+510
+5% +$32.8K 0.26% 90
2013
Q3
$575K Buy
10,125
+470
+5% +$28K 0.22% 108
2013
Q2
$552K Buy
+9,655
New +$559K 0.2% 108

Other funds holding CVS

San Francisco Sentry Investment Group's CVS Position: Q2 2021 in Review

San Francisco Sentry Investment Group increased its CVS Health (CVS) stake by 6.5% in Q2 2021, buying an estimated $30.3K and bringing the position to 6,065 shares worth $506K. The position accounts for 0.26% of the portfolio, ranked #106.

San Francisco Sentry Investment Group first reported a position in CVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.83M in Q1 2016. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • San Francisco Sentry Investment Group held 6,065 shares of CVS Health worth $506K as of Q2 2021.
  • San Francisco Sentry Investment Group bought 370 CVS Health shares in Q2 2021, an estimated $30.3K.
  • CVS Health made up 0.26% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #106 holding.
  • San Francisco Sentry Investment Group first reported a position in CVS Health in Q2 2013 and has held it in 33 quarters since.
  • San Francisco Sentry Investment Group's CVS Health position peaked at $1.83M in Q1 2016.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.